HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hidehito Horinouchi Selected Research
Hidehito Horinouchi Research Topics
Disease
71
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 08/2008
43
Neoplasms (Cancer)
11/2022 - 08/2011
13
Lung Neoplasms (Lung Cancer)
04/2022 - 07/2011
10
Disease Progression
05/2022 - 01/2015
7
Neutropenia
10/2020 - 08/2008
7
Thymoma (Thymic Carcinoma)
10/2020 - 08/2011
6
Interstitial Lung Diseases (Interstitial Lung Disease)
07/2022 - 04/2013
6
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 09/2009
5
Carcinoma (Carcinomatosis)
01/2022 - 07/2011
5
Adenocarcinoma of Lung
11/2021 - 04/2012
5
Neoplasm Metastasis (Metastasis)
01/2020 - 04/2013
4
Leukopenia
01/2020 - 07/2014
3
Pneumonia (Pneumonitis)
10/2022 - 09/2009
3
Thrombocytopenia (Thrombopenia)
01/2020 - 07/2014
2
Stomach Neoplasms (Stomach Cancer)
01/2022 - 12/2016
2
Exanthema (Rash)
10/2020 - 01/2017
2
Adrenal Insufficiency (Adrenal Gland Hypofunction)
03/2020 - 01/2019
2
Osteosarcoma (Osteogenic Sarcoma)
01/2020 - 02/2014
2
Anemia
01/2020 - 11/2015
2
Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 12/2016
2
Brain Neoplasms (Brain Tumor)
04/2013 - 04/2012
1
Overweight
03/2022
1
Cachexia
02/2022
1
Adenocarcinoma
01/2022
1
Lymphoma (Lymphomas)
01/2022
1
Fatigue
10/2020
1
Pleurisy (Pleuritis)
05/2020
1
Pericarditis
05/2020
1
Febrile Neutropenia
01/2020
1
Malignant Mesothelioma
11/2019
Drug/Important Bio-Agent (IBA)
16
ErbB Receptors (EGF Receptor)
IBA
01/2022 - 01/2012
13
Tyrosine Kinase Inhibitors
IBA
07/2019 - 01/2012
12
Nivolumab
IBA
01/2022 - 10/2018
10
pembrolizumab
IBA
10/2022 - 12/2020
10
Cisplatin (Platino)
FDA Link
Generic
04/2022 - 02/2012
10
B7-H1 Antigen
IBA
03/2022 - 05/2015
9
Immune Checkpoint Inhibitors
IBA
03/2022 - 03/2016
8
Pharmaceutical Preparations
IBA
07/2022 - 01/2012
7
Platinum
IBA
01/2022 - 04/2012
7
Ligands
IBA
01/2022 - 05/2015
7
Biomarkers (Surrogate Marker)
IBA
11/2021 - 06/2015
7
Carboplatin (JM8)
FDA Link
Generic
01/2020 - 08/2011
6
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2022 - 04/2013
5
Gefitinib (Iressa)
FDA Link
07/2021 - 04/2013
5
Monoclonal Antibodies
IBA
11/2019 - 06/2015
5
Paclitaxel (Taxol)
FDA Link
Generic
01/2017 - 08/2011
4
Pemetrexed (MTA)
FDA Link
08/2021 - 04/2013
4
Alanine Transaminase (SGPT)
IBA
10/2020 - 11/2015
4
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
07/2020 - 07/2014
4
Docetaxel (Taxotere)
FDA Link
01/2020 - 10/2018
3
alectinib
IBA
05/2022 - 01/2017
3
nintedanib
IBA
03/2022 - 01/2018
3
Solutions
IBA
12/2021 - 01/2018
3
Crizotinib
IBA
03/2020 - 08/2016
3
amrubicin
IBA
11/2019 - 07/2011
3
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
01/2019 - 11/2015
3
Vinorelbine (Navelbine)
FDA Link
Generic
08/2013 - 02/2012
2
Antineoplastic Agents (Antineoplastics)
IBA
07/2022 - 07/2022
2
durvalumab
IBA
04/2022 - 01/2022
2
Antiemetics
IBA
04/2022 - 05/2020
2
Enzymes
IBA
04/2022 - 10/2018
2
Ipilimumab
IBA
01/2022 - 08/2015
2
Ramucirumab
IBA
01/2022 - 01/2019
2
Programmed Cell Death 1 Receptor
IBA
01/2021 - 10/2018
2
osimertinib
IBA
01/2019 - 07/2017
2
Phosphotransferases (Kinase)
IBA
01/2019 - 07/2014
2
Anaplastic Lymphoma Kinase
IBA
09/2018 - 01/2017
2
ceritinib
IBA
09/2018 - 01/2017
2
DNA (Deoxyribonucleic Acid)
IBA
01/2018 - 02/2016
2
patritumab
IBA
12/2016 - 06/2015
2
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
02/2016 - 07/2014
2
linifanib
IBA
02/2016 - 07/2014
1
Dexamethasone (Maxidex)
FDA Link
Generic
04/2022
1
Aprepitant (Emend)
FDA Link
04/2022
1
Cytochrome P-450 CYP3A
IBA
04/2022
1
Leptin
IBA
02/2022
1
Interleukin-1alpha (Interleukin 1 alpha)
IBA
02/2022
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
02/2022
1
Interleukin-8 (Interleukin 8)
IBA
02/2022
1
Hormones (Hormone)
IBA
02/2022
1
Interleukin-10 (Interleukin 10)
IBA
02/2022
1
Cytokines
IBA
02/2022
1
Metalloproteins
IBA
11/2021
1
MicroRNAs (MicroRNA)
IBA
11/2021
1
Transforming Growth Factor beta (TGF-beta)
IBA
11/2021
1
Death Domain Receptors
IBA
01/2021
1
Afatinib
IBA
11/2020
1
Glycoproteins (Glycoprotein)
IBA
11/2019
1
Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)
IBA
11/2019
Therapy/Procedure
31
Drug Therapy (Chemotherapy)
11/2022 - 09/2009
29
Therapeutics
07/2022 - 08/2008
12
Chemoradiotherapy
04/2022 - 01/2012
9
Radiotherapy
11/2021 - 01/2012
4
Combination Drug Therapy (Combination Chemotherapy)
01/2022 - 08/2008
2
Neoadjuvant Therapy
01/2022 - 01/2020
2
Molecular Targeted Therapy
01/2022 - 12/2015
2
Immunotherapy
11/2021 - 05/2015
1
Gastrectomy
01/2022
1
Lasers (Laser)
01/2022
1
Drug Tapering
01/2020